Benzinga - Fri, 05 Mar 2021 06:37:42 -0400
Benzinga - Thu, 04 Mar 2021 11:38:17 -0400
Benzinga - Tue, 02 Mar 2021 05:48:59 -0400
Benzinga - Mon, 01 Mar 2021 13:19:44 -0400
Benzinga - Tue, 23 Feb 2021 05:58:31 -0400
Benzinga - Mon, 22 Feb 2021 13:34:13 -0400
Benzinga - Mon, 22 Feb 2021 13:00:15 -0400
Benzinga - Mon, 22 Feb 2021 05:59:48 -0400
Benzinga - Fri, 19 Feb 2021 13:47:30 -0400
Benzinga - Fri, 05 Feb 2021 08:43:46 -0400
Benzinga - Thu, 04 Feb 2021 12:08:48 -0400
Benzinga - Thu, 04 Feb 2021 08:21:57 -0400
Benzinga - Thu, 28 Jan 2021 06:40:37 -0400
Benzinga - Mon, 25 Jan 2021 15:34:13 -0400
Benzinga - Thu, 21 Jan 2021 09:05:24 -0400
load more
Sector: Health Care.Industry: Biotechnology
BioVie Inc is active in the healthcare domain in the United States. The company is a development stage enterprise engaged in the discovery, development, and commercialization of a therapy targeting ascites due to liver cirrhosis. Its therapy BIV201 is based on a drug that is approved in about 40 countries to treat related complications of liver cirrhosis. BioVie is developing BIV201 for alleviating the portal hypertension and correcting splanchnic vasodilation, thereby increasing effective blood volume and reducing the signals to the kidneys to retain excess salt and water.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-04-25
REV
Q4 2020Est.ActualSurprise
EPS-0.270
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BIVIBioVie3%205.7M

BioVie Company Questions & Answers

Q

How do I buy BioVie (BIVI) stock?

A

You can purchase shares of BioVie (NASDAQ: BIVI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioVie's (BIVI) main competitors?

A

Other companies in BioVie’s space includes: Calithera Biosciences (NASDAQ:CALA), Genprex (NASDAQ:GNPX) and Concert Pharmaceuticals (NASDAQ:CNCE).

Q

What is the target price for BioVie?

A

The latest price target for BioVie (NASDAQ: BIVI) was reported by B. Riley FBR on 2021-01-15. The analyst firm set a price target for 47.00 expecting BIVI to rise to within 12 months (a possible 218.00% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is BioVie (BIVI) stock ?

A

The stock price for BioVie (NASDAQ: BIVI) is $14.78 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next BioVie (BIVI) dividend?

A

There are no upcoming dividends for BioVie.

Q

When is BioVie (NASDAQ:BIVI) reporting earnings?

A
BioVie’s Q1 earnings are confirmed after-market from now on April 25, 2021.
Q

When is the upcoming split for BIVI?

A

There is no upcoming split for BioVie.